Im blickfeld: Das IQWiG-methodenpapier zur Kosten-nutzen-bewertung

In February 2008, the German IQWiG (Institute for Quality and Economic Efficiency in Health Care) published a first draft of a cost-benefit assessment methodology. This draft has been heavily criticized by experts in the field. The transparence and dialogue with relevant stakeholders (patients, clinicians, professional societies, industry) demanded in the law has not been implemented yet. It seems that the proposed concept of efficiency frontiers discriminates innovations and does not seem operationally feasible. When conducting cost-benefit assessments it is crucial to take into account cost savings that accrue to patients, providers, employers and the public health. It is therefore internationally well accepted to conduct such assessments from the so-called societal perspective. In conclusion, it is crucial that the proposed draft will be revised together with all stakeholders concerned directly or indirectly, addressing the raised points of criticism.